Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $108.0 million.

  • Standard Biotools' Total Current Liabilities fell 1048.79% to $108.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.0 million, marking a year-over-year decrease of 1048.79%. This contributed to the annual value of $65.9 million for FY2024, which is 3972.67% down from last year.
  • As of Q3 2025, Standard Biotools' Total Current Liabilities stood at $108.0 million, which was down 1048.79% from $98.0 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Total Current Liabilities registered a high of $123.8 million during Q2 2024, and its lowest value of $42.8 million during Q2 2022.
  • For the 5-year period, Standard Biotools' Total Current Liabilities averaged around $69.9 million, with its median value being $52.8 million (2021).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 17760.29% in 2024, then crashed by 5373.58% in 2025.
  • Standard Biotools' Total Current Liabilities (Quarter) stood at $49.6 million in 2021, then dropped by 12.36% to $43.4 million in 2022, then soared by 151.66% to $109.3 million in 2023, then tumbled by 39.73% to $65.9 million in 2024, then surged by 63.84% to $108.0 million in 2025.
  • Its Total Current Liabilities was $108.0 million in Q3 2025, compared to $98.0 million in Q2 2025 and $56.2 million in Q1 2025.